Christine Erikstrup Hallgreen

Christine Erikstrup Hallgreen

Associate Professor

Member of:


    1. 2023
    2. In preparation

      Clinical evidence and use of extrapolation in European biosimilar marketing authorizations

      Druedahl, Louise C., Vive Nielsen, C. & Hallgreen, Christine Erikstrup, 2023, (In preparation) In: BioDrugs.

      Research output: Contribution to journalJournal articleResearchpeer-review

    3. Published

      Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study

      Abtahi, S., Pajouheshnia, R., Durán, C. E., Riera-Arnau, J., Gamba, M., Alsina, E., Hoxhaj, V., Andersen, M., Bartolini, C., Kristiansen, S. B., Brown, J., Hallgreen, C. E., Garcia-Poza, P., Gardarsdottir, H., Gini, R., Girardi, A., Holthuis, E., Huerta, C., Ibánez, L., Limoncella, G. & 8 others, Martín-Pérez, M., Paoletti, O., Roberto, G., Souverein, P., Swart, K. M. A., Wing, K., Sturkenboom, M. & Klungel, O., 2023, In: Drug Safety. 46, 7, p. 689-702

      Research output: Contribution to journalJournal articleResearchpeer-review

    4. Published

      Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis

      Durán, C. E., Riera-Arnau, J., Abtahi, S., Pajouheshnia, R., Hoxhaj, V., Gamba, M., Alsina, E., Martin-Perez, M., Garcia-Poza, P., Llorente-Garcia, A., Gonzalez-Bermejo, D., Ibánez, L., Sabaté, M., Vidal, X., Ballarín, E., Sanfélix-Gimeno, G., Rodríguez-Bernal, C., Peiró, S., García-Sempere, A., Sanchez-Saez, F. & 22 others, Ientile, V., Ingrasciotta, Y., Guarneri, C., Tanaglia, M., Tari, M., Herings, R., Houben, E., Swart-Polinder, K., Holthuis, E., Huerta, C., Gini, R., Roberto, G., Bartolini, C., Paoletti, O., Limoncella, G., Girardi, A., Hyeraci, G., Andersen, Morten, Kristiansen, S. B., Hallgreen, Christine Erikstrup, Klungel, O. & Sturkenboom, M., 2023, In: Frontiers in Pharmacology. 14, 12 p., 1207976.

      Research output: Contribution to journalJournal articleResearchpeer-review

    5. Submitted

      Implementation of electronic distribution of Direct Healthcare Professional Communications (DHPCs) by the Danish Medicines Agency: A survey study of physicians’ experiences and preferences

      Sindahl, P., Møllebæk, Mathias, Gardarsdottir, H., De Bruin, M. L. (., Hallgreen, Christine Erikstrup & Clemmensen, M. H., 2023, (Submitted) In: Therapeutic Advances in Drug Safety.

      Research output: Contribution to journalJournal articleResearchpeer-review

    6. 2022
    7. Published

      Flash presentation: Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Valproates

      Abtahi, S., Pajouheshnia, R., Duran-Salinas, C., Riera-Arnau, J., Gamba, M., Alsina, E., Hallgreen, Christine Erikstrup, Limoncella, G., Bartolini, C., Holthuis, E., Martin-Perez, M., Brown, J., Sturkenboom, M., Klungel, O. & Lot, O., 2022, In: Drug Safety. 45, 10, p. 1312-1313

      Research output: Contribution to journalConference abstract in journalResearchpeer-review

    8. Published

      Guidance for pediatric use in prescription information for novel medicinal products in the EU and the US

      Christiansen, H., De Bruin, M. L., Frøkjær, Sven & Hallgreen, Christine Erikstrup, 2022, In: PLoS ONE. 17, 4, 19 p., e0266353.

      Research output: Contribution to journalJournal articleResearchpeer-review

    9. Published

      Hydroxysine initiation following drug safety advisories on cardiac arrhythmias in the UK and Canada: A longitudinal cohort study

      Morrow, R., Mintzes, B., Souverein, P., Hallgreen, Christine Erikstrup, Ahmed, B., Roughead, E., De Bruin, M. L., Kristiansen, S., Lexchin, J., Kemp-Casey, A., Sketris, I., Mangin, D., Pearson, S., Puil, L., Lopert, R., Bero, L., Gnjidic, D., Sarpatwari, A. & Dormuth, C., 2022, In: Pharmacoepidemiology and Drug Safety. 31, S2, p. 76-76 1 p.

      Research output: Contribution to journalConference abstract in journalResearchpeer-review

    10. Published

      Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study

      Morrow, R. L., Mintzes, B., Souverein, P. C., Hallgreen, Christine Erikstrup, Ahmed, B., Roughead, E. E., De Bruin, M. L., Kristiansen, S. B., Lexchin, J., Kemp-Casey, A., Sketris, I., Mangin, D., Pearson, S. A., Puil, L., Lopert, R., Bero, L., Gnjidic, D., Sarpatwari, A. & Dormuth, C. R., 2022, In: Drug Safety. 45, p. 623–638

      Research output: Contribution to journalJournal articleResearchpeer-review

    11. Published

      Impact of regulatory interventions to restrict the combined use of renin-angiotensin system-acting agents: A Danish nationwide drug utilisation study

      Sindahl, Per, Ofori-Asenso, R., Hallgreen, Christine Erikstrup, Kemp, K., Gardarsdottir, H. & Bruin, M. L. D., 2022, In: British Journal of Clinical Pharmacology. 88, 3, p. 1379-1384

      Research output: Contribution to journalJournal articleResearchpeer-review

    12. Published

      Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis

      Morrow, R. L., Mintzes, B., Souverein, P. C., De Bruin, M. L., Roughead, E. E., Lexchin, J., Kemp-Casey, A., Puil, L., Sketris, I., Mangin, D., Hallgreen, Christine Erikstrup, Pearson, S., Lopert, R., Bero, L., Ofori-Asenso, R., Gnjidic, D., Sarpatwari, A., Perry, L. T. & Dormuth, C. R., 2022, In: BMJ quality & safety. 31, 3, p. 179–190

      Research output: Contribution to journalJournal articleResearchpeer-review

    13. Published

      Mandatory requirements for pediatric drug development in the EU and the US for novel drugs: A comparative study

      Christiansen, Helle, De Bruin, M. L. & Hallgreen, Christine Erikstrup, 2022, In: Frontiers in Medicine. 9, 11 p., 1009432.

      Research output: Contribution to journalJournal articleResearchpeer-review

    14. Published

      Marketing authorization pathways and clinical evidence supporting approval of orphan medicinal products in EU between January 2015 and October 2021

      Hallgreen, Christine Erikstrup, Møllebæk, Mathias & Corap, E., 2022, In: Pharmacoepidemiology and Drug Safety. 31, S2, p. 266-267

      Research output: Contribution to journalConference abstract in journalResearchpeer-review

    15. Published

      Medication Adherence Measurement Methods in Registration Trials Supporting the Approval of New Medicines: A Cross-Sectional Analysis of Centralized Procedures in the European Union 2010–2020

      Mantila, K. M., Pasmooij, A. M. G., Hallgreen, Christine Erikstrup, Mol, P. G. M. & van Boven, J. F. M., 2022, In: Clinical Pharmacology and Therapeutics. 112, 5, p. 1051-1060

      Research output: Contribution to journalJournal articleResearchpeer-review

    16. Published

      Medication adherence in registration trials supporting the approval of new medicines in the European Union

      Mantila, K. M., Mol, P. G. M., Pasmooij, M., Hallgreen, Christine Erikstrup & van Boven, J. F. M., 2022, In: International Journal of Clinical Pharmacy. 44, 1, p. 279-280

      Research output: Contribution to journalConference abstract in journalResearchpeer-review

    17. Published

      New Information on Old Medicinal Products: A Cross-Sectional Analysis of Guidance for Paediatric Use for Substances on the European Priority List of Off-Patent Medicinal Products

      Mogensen, A. K. B., Christiansen, Helle, De Bruin, M. L. & Hallgreen, Christine Erikstrup, 2022, In: Pediatric Drugs. 24, p. 679–687

      Research output: Contribution to journalJournal articleResearchpeer-review

    18. Published

      Status of Planned and Ongoing Paediatric Trials Investigating COVID-19 Vaccines: A Cross-Sectional Study of Paediatric Clinical Trials Planned in Agreed PIPs and/or Registered in Clinical Trial Databases

      Christiansen, H., Thirstrup, Steffen & Hallgreen, Christine Erikstrup, 2022, In: Therapeutic Innovation & Regulatory Science. 56, p. 474–482

      Research output: Contribution to journalJournal articleResearchpeer-review

    19. 2021
    20. Published

      Influence of drug safety advisories on drug utilization: An international interrupted time series and meta-analysis study

      Morrow, R. L., Mintzes, B., Souverein, P. C., De Bruin, M. L., Roughead, E. E., Lexchin, J., Kemp-Casey, A., Puil, L., Sketris, I., Mangin, D., Hallgreen, Christine Erikstrup, Pearson, S., Lopert, R., Bero, L., Ofori-Asenso, R., Gnjidic, D., Sarpatwari, A. & Dormuth, C. R., Aug 2021, In: Pharmacoepidemiology and Drug Safety. 30, S1, p. 33-34

      Research output: Contribution to journalConference abstract in journalResearch

    21. 2020
    22. Published

      Are monitoring instructions provided in direct healthcare professional communications (DHPCs) of sufficient quality? A retrospective analysis of DHPCs sent out between 2007 and 2018

      Højer, M. G., De Bruin, M. L., Boskovic, A. & Hallgreen, Christine Erikstrup, 2020, In: BMJ Open. 10, 5, 9 p., e036498.

      Research output: Contribution to journalJournal articleResearchpeer-review

    23. Published

      Comparison of electronic self-reported prescription medication use during pregnancy with the national prescription register in Denmark

      Laursen, M., Hallgreen, Christine Erikstrup, Dreyer, N., Bourke, A., Mt-Isa, S. & Blackburn, S., 2020, In: Pharmacoepidemiology and Drug Safety. 29, 3, p. 328-336

      Research output: Contribution to journalJournal articleResearchpeer-review

    24. Published

      How and Why to Involve Patients in Drug Development: Perspectives from the Pharmaceutical Industry, Regulatory Authorities and Patient Organizations

      Hansen, M. B., Nørgaard, Lotte Stig & Hallgreen, Christine Erikstrup, 2020, In: Therapeutic Innovation & Regulatory Science. 54, p. 577-585 9 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    25. Published

      Improving Interactions Between Health Technology Assessment Bodies and Regulatory Agencies: A Systematic Review and Cross-Sectional Survey on Processes, Progress, Outcomes, and Challenges

      Ofori-Asenso, R., Hallgreen, Christine Erikstrup & De Bruin, M. L., 2020, In: Frontiers in Medicine. 7, 17 p., 582634.

      Research output: Contribution to journalReviewResearchpeer-review

    26. 2019
    27. Published

      Impact of European Benefit-Risk reassessment procedures on drug prescribing practices in Denmark

      De Bruin, M. L. (., Hallgreen, Christine Erikstrup & Andersen, Morten, Aug 2019.

      Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

    28. Published

      The effectiveness of direct to healthcare professional communication – A systematic review of communication factor studies

      Møllebæk, Mathias, Kaae, Susanne, De Bruin, M. L., Callréus, T., Jossan, S. & Hallgreen, Christine Erikstrup, May 2019, In: Research in Social and Administrative Pharmacy. 15, 5, p. 475-482

      Research output: Contribution to journalReviewResearchpeer-review

    29. 2018
    30. Published

      Impact of the 2012 pharmacovigilance legislation on the harmonisation of DHPCS in the EU

      Olafsdottir, G., Bukhave, S. M., Kalligeros, G., Hallgreen, Christine Erikstrup & De Bruin, M. L., Aug 2018, p. 515-516.

      Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

    31. 2017
    32. Published

      How to Measure the Impact of Pharmacovigilance Activities on Public Health?

      Gardarsdottir, H., Kant, A., De Bruin, M. L., Hallgreen, Christine Erikstrup, Dal Pan, G. & Way, D., Aug 2017, p. 31-31.

      Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

    33. Published

      Differences and similarities in medicine use, perceptions and sharing among adolescents in two different educational settings

      Vestergaard, Stense Kromann, Hallgreen, Christine Erikstrup, Ravn, P. & Kaae, Susanne, 2017, In: International Journal of Adolescent Medicine and Health. DOI: https://doi.org/10.1515/ijamh-2017-0097, 9 p., 0097.

      Research output: Contribution to journalJournal articleResearchpeer-review

    34. 2016
    35. Published

      Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance

      Aagaard, L., Hallgreen, Christine Erikstrup & Hansen, E. H., Nov 2016, In: International journal of obesity (2005). 40, 11, p. 1742-1747 6 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    36. Literature review of visual representation of the results of benefit-risk assessments of medicinal products

      Hallgreen, Christine Erikstrup, Mt-Isa, S., Lieftucht, A., Phillips, L. D., Hughes, D., Talbot, S., Asiimwe, A., Downey, G., Genov, G., Hermann, R., Noel, R., Peters, R., Micaleff, A., Tzoulaki, I., Ashby, D. & PROTECT Benefit-Risk Group, P. B. G., Mar 2016, In: Pharmacoepidemiology and Drug Safety. 25, 3, p. 238-50 13 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    37. Published

      Recommendations for benefit-risk assessment methodologies and visual representations

      Hughes, D., Waddingham, E., Mt-Isa, S., Goginsky, A., Chan, E., Downey, G. F., Hallgreen, Christine Erikstrup, Hockley, K. S., Juhaeri, J., Lieftucht, A., Metcalf, M. A., Noel, R. A., Phillips, L. D., Ashby, D., Micaleff, A. & PROTECT Benefit-Risk Group, P. B. G., Mar 2016, In: Pharmacoepidemiology and Drug Safety. 25, 3, p. 251-62 12 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    38. 2014
    39. Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology

      Hallgreen, C. E., van den Ham, H. A., Mt-Isa, S., Ashworth, S., Hermann, R., Hobbiger, S., Luciani, D., Micaleff, A., Thomson, A., Wang, N., van Staa, T. P., Downey, G., Hirsch, I., Hockley, K., Juhaeri, J., Metcalf, M., Mwangi, J., Nixon, R., Peters, R., Stoeckert, I. & 4 others, Waddingham, E., Tzoulaki, I., Ashby, D. & Wise, L., Sep 2014, In: Pharmacoepidemiology and Drug Safety. 23, 9, p. 974-983 10 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    40. Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

      Mt-Isa, S., Hallgreen, Christine Erikstrup, Wang, N., Callréus, T., Genov, G., Hirsch, I., Hobbiger, S. F., Hockley, K. S., Luciani, D., Phillips, L. D., Quartey, G., Sarac, S. B., Stoeckert, I., Tzoulaki, I., Micaleff, A., Ashby, D. & IMI-PROTECT benefit-risk participants, I. B. P., Jul 2014, In: Pharmacoepidemiology and Drug Safety. 23, 7, p. 667-78 12 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    41. 2009
    42. Published

      A model of NEFA dynamics with focus on the postprandial state

      Jelic, K., Hallgreen, Christine Erikstrup & Colding-Jørgensen, M., Sep 2009, In: Annals of Biomedical Engineering. 37, 9, p. 1897-1909 13 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    43. 2008
    44. Published

      Allometric relationship between changes of visceral fat and total fat mass

      Hallgreen, Christine Erikstrup & Hall, K. D., May 2008, In: International Journal of Obesity. 32, 5, p. 845-852 8 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    45. Published

      Increasing weight loss attenuates the preferential loss of visceral compared with subcutaneous fat: A predicted result of an allometric model

      Hall, K. D. & Hallgreen, Christine Erikstrup, Apr 2008, In: International Journal of Obesity. 32, 4, p. 722 1 p.

      Research output: Contribution to journalLetterResearchpeer-review

    46. The Glucose-Insulin Control System

      Hallgreen, Christine Erikstrup, Korsgaard, T. V., Hansen, R. N. & Colding-Jørgensen, M., 2008, Biosimulation in Drug Development. Wiley, p. 141-196 56 p.

      Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

    ID: 122745397